Transaction in Own Shares

RNS Number : 3618Z
Trian Investors 1 Limited
21 May 2021
 

21 May 2021

 

TRIAN INVESTORS 1 LIMITED
(the "Company")

 

Transaction in Own Shares

 

The Board of Trian Investors 1 Limited announces that, in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 1 September 2020, on 20 May 2021 the Company purchased 1,600,000 of its own ordinary shares ("Ordinary Shares") at a price of 127p per share. These shares will be held as treasury shares.

 

Following this transaction, the total number of Ordinary Shares held as treasury shares by the Company is 10,716,913. The total number of Ordinary Shares in issue (excluding shares held as treasury shares) is 259,869,064.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the schedule below contains detailed information about the individual purchases made by Numis and Jefferies on behalf of the Company as part of the share repurchase programme.

 

For further information, please contact:

 

Ocorian Administration (Guernsey) Limited
(Administrator and Company Secretary)

+44 (0)1481 742 742
Ian Smith

 

 


 

Schedule of Purchases

Shares purchased:  Trian Investors 1 Limited (ISIN CODE: GG00BF52MW15)

Date of purchases:  20 May 2021

Investment firm:  Numis Securities Limited

 

Shares purchased:  Trian Investors 1 Limited (ISIN CODE: GG00BF52MW15)

Date of purchases:  20 May 2021

Investment firm:  Jefferies International Limited

 

 Aggregate information:

Venue

Volume-weighted

average price, pence

Aggregated volume

London Stock Exchange

127p

1,600,000

 

Individual transaction:

Number of shares purchased

Transaction price
(pence per share)

Time of transaction

Trading venue

1,100,000

127p

13:43

London Stock Exchange

500,000

127p

16:23

London Stock Exchange

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSVBLFLFELLBBE
UK 100

Latest directors dealings